Literature DB >> 15830457

Incidence and costs of accidents among attention-deficit/hyperactivity disorder patients.

Andrine Swensen1, Howard G Birnbaum, Rym Ben Hamadi, Paul Greenberg, Pierre-Yves Cremieux, Kristina Secnik.   

Abstract

PURPOSE: The purpose is to analyze the incidence and costs of accidents among Attention-Deficit/Hyperactivity Disorder (ADHD) patients.
METHODS: The analysis relied on administrative medical, pharmaceutical, and disability claims for a national manufacturer's employees, spouses, dependents, and retirees (n > 100,000). Accidental injuries were identified using ICD-9 codes for injuries or poisoning treatment. ADHD sample consists of individuals with at least one claim for ADHD during 1996-98 (NADHD = 1308), which was compared with a matched control sample. In addition to descriptive statistics, multivariate analysis involving logistic regression was used to model the probability of having an accident claim in 1998. This probability was estimated for the whole population, for adults alone, for children (under age 12 years), and for adolescents (age 12-18 years). We also estimated a generalized estimation equation (GEE) model to account for the possibility of multiple accident claims for a single patient.
RESULTS: ADHD patients had a greater probability of having at least one accident claim than their controls for children (28% vs. 18%), adolescents (32% vs. 23%), and adults (38% vs. 18%). Although ADHD patients' costs were greater than their controls for adults ($483 vs. $146), there was no difference for children or adolescents. However, among patients with accident claims, the average number of accident claims was similar for both groups (3.6 vs. 3.5) and costs were not statistically different. The multivariate analysis confirms this utilization pattern: the odds of having an accident for ADHD patients were 1.7 times greater than for controls.
CONCLUSIONS: ADHD was a significant predictor of having an accident claim. However, for people with an accident claim, ADHD patients and controls had a similar number of accident claims and costs.

Entities:  

Mesh:

Year:  2004        PMID: 15830457

Source DB:  PubMed          Journal:  J Adolesc Health        ISSN: 1054-139X            Impact factor:   5.012


  41 in total

1.  Memory-guided force output is associated with self-reported ADHD symptoms in young adults.

Authors:  Kristina A Neely; Amanda P Chennavasin; Arie Yoder; Genevieve K R Williams; Eric Loken; Cynthia L Huang-Pollock
Journal:  Exp Brain Res       Date:  2016-07-09       Impact factor: 1.972

2.  Using a Brief Parent-Report Measure to Track Outcomes for Children and Teens with ADHD.

Authors:  Alyssa McCarthy; Sunna Asghar; Timothy Wilens; Stephanie Romo; Hayley Kamin; Michael Jellinek; Michael Murphy
Journal:  Child Psychiatry Hum Dev       Date:  2016-06

Review 3.  A comprehensive scoping review of ability and disability in ADHD using the International Classification of Functioning, Disability and Health-Children and Youth Version (ICF-CY).

Authors:  Elles de Schipper; Aiko Lundequist; Anna Löfgren Wilteus; David Coghill; Petrus J de Vries; Mats Granlund; Martin Holtmann; Ulf Jonsson; Sunil Karande; Florence Levy; Omar Al-Modayfer; Luis Rohde; Rosemary Tannock; Bruce Tonge; Sven Bölte
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-06-03       Impact factor: 4.785

4.  Mild Traumatic Brain Injury and Attention-Deficit Hyperactivity Disorder in Young Student Athletes.

Authors:  Joseph Biederman; Leah Feinberg; James Chan; Bamidele O Adeyemo; K Yvonne Woodworth; Walter Panis; Neal McGrath; Saurabha Bhatnagar; Thomas J Spencer; Mai Uchida; Tara Kenworthy; Rebecca Grossman; Ross Zafonte; Stephen V Faraone
Journal:  J Nerv Ment Dis       Date:  2015-11       Impact factor: 2.254

5.  ADHD, depression, and motor vehicle crashes: A prospective cohort study of continuously-monitored, real-world driving.

Authors:  Paula A Aduen; Michael J Kofler; Dustin E Sarver; Erica L Wells; Elia F Soto; Daniel J Cox
Journal:  J Psychiatr Res       Date:  2018-03-06       Impact factor: 4.791

6.  Mental Health Conditions and Medical and Surgical Hospital Utilization.

Authors:  Stephanie K Doupnik; John Lawlor; Bonnie T Zima; Tumaini R Coker; Naomi S Bardach; Matt Hall; Jay G Berry
Journal:  Pediatrics       Date:  2016-11-11       Impact factor: 7.124

Review 7.  European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD.

Authors:  Sandra J J Kooij; Susanne Bejerot; Andrew Blackwell; Herve Caci; Miquel Casas-Brugué; Pieter J Carpentier; Dan Edvinsson; John Fayyad; Karin Foeken; Michael Fitzgerald; Veronique Gaillac; Ylva Ginsberg; Chantal Henry; Johanna Krause; Michael B Lensing; Iris Manor; Helmut Niederhofer; Carlos Nunes-Filipe; Martin D Ohlmeier; Pierre Oswald; Stefano Pallanti; Artemios Pehlivanidis; Josep A Ramos-Quiroga; Maria Rastam; Doris Ryffel-Rawak; Steven Stes; Philip Asherson
Journal:  BMC Psychiatry       Date:  2010-09-03       Impact factor: 3.630

8.  Cognition assessment using the NIH Toolbox.

Authors:  Sandra Weintraub; Sureyya S Dikmen; Robert K Heaton; David S Tulsky; Philip D Zelazo; Patricia J Bauer; Noelle E Carlozzi; Jerry Slotkin; David Blitz; Kathleen Wallner-Allen; Nathan A Fox; Jennifer L Beaumont; Dan Mungas; Cindy J Nowinski; Jennifer Richler; Joanne A Deocampo; Jacob E Anderson; Jennifer J Manly; Beth Borosh; Richard Havlik; Kevin Conway; Emmeline Edwards; Lisa Freund; Jonathan W King; Claudia Moy; Ellen Witt; Richard C Gershon
Journal:  Neurology       Date:  2013-03-12       Impact factor: 9.910

9.  First treatment contact for ADHD: predictors of and gender differences in treatment seeking.

Authors:  Elias Dakwar; Frances R Levin; Mark Olfson; Shuai Wang; Bradley Kerridge; Carlos Blanco
Journal:  Psychiatr Serv       Date:  2014-10-31       Impact factor: 3.084

Review 10.  Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis.

Authors:  Kim Peterson; Marian S McDonagh; Rongwei Fu
Journal:  Psychopharmacology (Berl)       Date:  2007-11-17       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.